Biolargo, Inc. financial data

Symbol
BLGO on OTC
Industry
Chemicals & Allied Products
Location
14921 Chestnut St., Westminster, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
NUWAY MEDICAL INC (to 4/3/2007), NUWAY ENERGY INC (to 2/5/2003), LATIN AMERICAN CASINOS INC (to 2/15/2001)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 252 % +10.9%
Quick Ratio 7.14 % -48.3%
Debt-to-equity 47.5 % -4.25%
Operating Margin -37.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 296M shares +4.37%
Common Stock, Shares, Outstanding 293M shares +5.2%
Entity Public Float 40.9M USD +0.38%
Common Stock, Value, Issued 198K USD +4.21%
Weighted Average Number of Shares Outstanding, Basic 294M shares +4.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.2M USD
Research and Development Expense 2.5M USD +67.6%
Operating Income (Loss) -4.87M USD -17.1%
Earnings Per Share, Basic -0.02 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.34M USD +32.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.47M USD +79.2%
Inventory, Net 251K USD +85.9%
Assets, Current 7.18M USD +47.2%
Property, Plant and Equipment, Net 1.49M USD +281%
Operating Lease, Right-of-Use Asset 1.07M USD +27.6%
Other Assets, Noncurrent 70K USD -43.5%
Assets 9.82M USD +47.8%
Accounts Payable, Current 1.66M USD +60.1%
Employee-related Liabilities, Current 77K USD -51.9%
Contract with Customer, Liability, Current 261K USD +1143%
Liabilities, Current 3.4M USD +89.2%
Operating Lease, Liability, Noncurrent 985K USD +31.9%
Liabilities 4.67M USD +51%
Accumulated Other Comprehensive Income (Loss), Net of Tax -181K USD -16.8%
Retained Earnings (Accumulated Deficit) -148M USD -2.55%
Stockholders' Equity Attributable to Parent 8.12M USD +27.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.15M USD +44.9%
Liabilities and Equity 9.82M USD +47.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 481K USD
Net Cash Provided by (Used in) Financing Activities 1.08M USD -28.3%
Net Cash Provided by (Used in) Investing Activities -863K USD -1698%
Common Stock, Shares Authorized 550M shares 0%
Common Stock, Shares, Issued 296M shares +4.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 797K USD -43.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -20%
Deferred Tax Assets, Valuation Allowance 22.3M USD +4.42%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 1.09M USD +29.1%
Depreciation 36K USD +63.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.69M USD -19.1%
Lessee, Operating Lease, Liability, to be Paid 2.04M USD +13.9%
Operating Lease, Liability, Current 105K USD +8.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 289K USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year One 282K USD +4.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 933K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 296K USD +88.5%
Deferred Tax Assets, Operating Loss Carryforwards 22.3M USD +4.42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 245K USD +53.1%
Additional Paid in Capital 156M USD +3.61%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 338K USD -21.4%
Interest Expense 55K USD -37.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%